Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,166 GBX | +1.30% | -0.09% | +10.63% |
May. 08 | UBS raises Centrica to 'buy' from 'neutral | AN |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Sales 2024 * | 3.89B 4.95B | Sales 2025 * | 4.27B 5.44B | Capitalization | 4B 5.09B |
---|---|---|---|---|---|
Net income 2024 * | 469M 597M | Net income 2025 * | 504M 642M | EV / Sales 2024 * | 1.03 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.94 x |
P/E ratio 2024 * |
8.59
x | P/E ratio 2025 * |
7.88
x | Employees | 3,000 |
Yield 2024 * |
2.77% | Yield 2025 * |
3.07% | Free-Float | 97.45% |
Latest transcript on Hiscox Ltd
1 day | +1.30% | ||
1 week | -0.09% | ||
Current month | -5.20% | ||
1 month | -3.08% | ||
3 months | +6.97% | ||
6 months | +13.53% | ||
Current year | +10.63% |
Managers | Title | Age | Since |
---|---|---|---|
Hamayou Hussain
CEO | Chief Executive Officer | 51 | 16-04-21 |
Paul Cooper
DFI | Director of Finance/CFO | 52 | 22-05-11 |
Stéphane Flaquet
COO | Chief Operating Officer | - | 10-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | 17-11-15 | |
Anne MacDonald
BRD | Director/Board Member | 68 | 15-05-19 |
Colin Keogh
BRD | Director/Board Member | 69 | 15-11-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 746 M€ | -.--% | - | |
0.02% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 1,166 | +1.30% | 601,640 |
24-05-23 | 1,151 | -1.20% | 1,589,868 |
24-05-22 | 1,165 | +0.17% | 638,175 |
24-05-21 | 1,163 | +0.17% | 412,568 |
24-05-20 | 1,161 | -0.51% | 529,452 |
Delayed Quote London S.E., May 24, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.63% | 5.1B | |
+46.22% | 64.47B | |
+11.99% | 48.85B | |
+17.76% | 43.5B | |
+39.17% | 38.65B | |
+72.45% | 32.31B | |
+12.33% | 29.89B | |
+27.94% | 25.81B | |
+2.63% | 22.14B | |
+13.97% | 21.04B |
- Stock Market
- Equities
- HSX Stock